Biliary Cholangitis
📧 Sign up to get email alerts when something new happens for Biliary Cholangitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Monitoring the Response of Combination Ursodiol and Seladelpar Treatment
This document summarizes a planned clinical trial assessing the combination of Ursodiol and Seladelpar for primary biliary cholangitis, with…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC) [EARLY_Phase 1]
An early-phase 1 clinical trial evaluating fenofibrate in patients with Primary Biliary Cholangitis (PBC). The study is currently recruiting…
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis [Phase 2]
Phase 2 study update reporting results for EP547 in patients with cholestatic pruritus due to primary biliary cholangitis or primary scleros…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: National Database on Primary Biliary Cholangitis
A national database study on Primary Biliary Cholangitis sponsored by the University of Milano Bicocca is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN) [Phase 3]
Phase 3 GLISTEN trial evaluating linerixibat for pruritus in primary biliary cholangitis has completed and results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: A Study of the Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury [Phase 1]
A Phase 1 trial update on the pharmacokinetics and safety of the investigational drug CS0159 in subjects with hepatic injury, including thos…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Fenofibrate in Patients With Primary Biliary Cholangitis (PBC) [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating fenofibrate in patients with Primary Biliary Cholangitis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Trial of Psychoeducational and Hypnosis Interventions on the Fatigue Associated With PBC in Women [NA]
A completed clinical trial from Assistance Publique - Hôpitaux de Paris evaluating psychoeducational and hypnosis interventions to reduce fa…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis [Phase 2, Phase 3]
Clinical trial update indicating completion of Phase 2 and Phase 3 studies evaluating saroglitazar magnesium for Primary Biliary Cholangitis…
-
CLINICAL_TRIALS other · 2025-05-25Clinical Trial Update: Mindfulness - Based Intervention in the Treatment of Fatigue in Patients With Primary Biliary Cholangitis [NA]
A Yale University clinical trial evaluating a mindfulness-based intervention for fatigue in Primary Biliary Cholangitis has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and Safety of K-808 (Pemafibrate) in Subjects With Primary Biliary Cholangitis With Compensated Cirrhosis and Without Cirrhosis. [Phase 1]
Phase 1 study evaluating the pharmacokinetics and safety of pemafibrate (K-808) in subjects with primary biliary cholangitis with compensate…
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: LEOPARD Training and Validation Data Collection Study
LEOPARD is a training and validation data collection study that is currently recruiting to assemble data for liver disease conditions includ…
-
CLINICAL_TRIALS research · 2025-05-05Clinical Trial Update: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) [Phase 3]
This entry describes a Phase 3 clinical trial to evaluate whether seladelpar can normalize alkaline phosphatase levels in patients with Prim…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness [Phase 2]
The Phase 2 trial of Setanaxib in patients with primary biliary cholangitis has been completed, with results posted on 2025-04-24.
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: Clinical Research of Tapering UDCA in PBC Patients With a Complete Response [Phase 4]
Phase 4 clinical trial evaluating tapering ursodeoxycholic acid in primary biliary cholangitis patients who have achieved a complete respons…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Performance of Scoring Systems in Chinese Patients With Primary Biliary Cholangitis (PBC) on Ursodeoxycholic Acid
This completed clinical trial evaluates how well scoring systems perform in Chinese patients with primary biliary cholangitis who are treate…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI) [Phase 1]
An open-label Phase 1 study evaluating oral dosing of seladelpar in adults with primary biliary cholangitis and hepatic impairment (compensa…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: EMPower Mechanisms [NA]
A clinical trial update indicates EMPower Mechanisms (NCT06861465) is recruiting for Primary Biliary Cholangitis at the University of Albert…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Linerixibat Compassionate Use for Cholestatic Pruritus Adult Patients With Primary Biliary Cholangitis (PBC)
This clinical trial update describes compassionate-use access to linerixibat for adults with cholestatic pruritus due to primary biliary cho…
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Study to Evaluate the Effects of Two Doses of Seladelpar (MBX-8025) in Subjects With Primary Biliary Cirrhosis (PBC) [Phase 2]
A Phase 2 study evaluating two doses of seladelpar (MBX-8025) for primary biliary cholangitis was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients
A real-world data study evaluating the effectiveness of obeticholic acid (Ocaliva) on hepatic outcomes in patients with primary biliary chol…
-
EMA withdrawal · 2025-01-20EMA Revoked: Ocaliva (obeticholic acid) — Advanz Pharma Limited
EMA revoked the marketing authorization for Ocaliva (obeticholic acid) held by Advanz Pharma Limited, effective 16 April 2024, for biliary/l…
-
CLINICAL_TRIALS other · 2025-01-10Clinical Trial Update: Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai)
The ColHai registry in Spain is currently recruiting and focuses on autoimmune and cholestatic liver diseases, including autoimmune hepatiti…
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Evidence Based Mental Wellness Programming Online for Adults Across Chronic Physical Conditions [NA]
The document reports completion of a clinical trial evaluating an online mental wellness program for adults across multiple chronic conditio…
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: LEOPARD Prospective Validation Cohort 1
This clinical trial update describes the LEOPARD prospective validation cohort 1 by Assistance Publique - Hôpitaux de Paris and lists condit…